Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for refining and crushing rivaroxaban bulk drug

A technology of rivaroxaban and raw materials, applied in the direction of organic chemistry, etc., can solve the problems of difficult cleaning of mother liquor, high requirements for drop rate control, and difficult filtration

Pending Publication Date: 2022-07-01
JIANGSU SINOBIOPHARMA
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The defect of this method is that the process of dripping rivaroxaban organic solution into water in a stirring state requires very high drop rate control. Once the drop rate control is not good, the particle size of the product cannot meet the requirements; in addition, the product with this particle size There are defects such as difficult filtration, mother liquor is difficult to wash and residual impurities, and there are great difficulties in industrial production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for refining and crushing rivaroxaban bulk drug

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] Preparation of crude rivaroxaban: add 10.9kg of drinking water and 1.3kg of anhydrous sodium carbonate to a 50L reaction kettle, and stir until dissolved completely. Then add 3.7kg of acetone, cool down and stir to 5±5℃. Keeping the system temperature at 5±5°C, 2.0kg of 4-[4-[(5S)-5-(aminomethyl)-2-oxo-3-oxazolidinyl]phenyl]-3- Morpholinone hydrochloride was added in the reaction kettle, and then the toluene solution of 5-chlorothiophene-2-formyl chloride was slowly added dropwise (1.7kg of 5-chlorothiophene-2-formyl chloride was added to 3.5kg of toluene), and the stirring 30min. The reaction system was heated to 55±5°C and kept stirring for 1 hour, and then the reaction system was cooled to 25±5°C and kept stirring for 2 hours for crystallization. The reaction solution was transferred to a centrifuge and filtered for 20 minutes, washed once with 16.0kg of acetone / water (mass ratio 1:5), and the obtained solid was transferred to a baking tray, at 55±5°C, vacuum degre...

Embodiment 2

[0022] Preparation of rivaroxaban to be pulverized: add 10.8kg of glacial acetic acid and 2.5kg of crude rivaroxaban (prepared in Example 1) into a 50L reactor, heat up and stir to reflux. After the solid was completely dissolved, a mixture of 0.1 kg of activated carbon and 0.5 kg of acetic acid was added, and the mixture was stirred under reflux for 0.5 hours. Gradient cooling of the reaction system to 25±5°C (naturally cooling to 80±5°C first, then naturally cooling to 50±5°C, and finally naturally cooling to 25±5°C), stirring and crystallization for 5 hours. The reaction solution was transferred to a centrifuge for filtration for 30 min, washed once with 4.0 kg of acetic acid and 10.5 kg of water, respectively, and the obtained solid was transferred to a baking tray, and dried to Constant weight, 1.9kg of rivaroxaban to be pulverized, yield 76.00%, after measurement, the particle size of rivaroxaban to be pulverized is X 90 = 279.53 μm.

Embodiment 3

[0024] Preparation of finished rivaroxaban: turn on the airflow pulverizer, set the feeding pressure to be 0.70-0.75Mpa, the pulverization pressure to be 0.50-0.75Mpa, and add 1.9kg of rivaroxaban to be pulverized (prepared in Example 2) into the airflow The feeding port of the pulverizer is used for pulverization. The pulverized sample was weighed and sealed to obtain 1.5kg of rivaroxaban finished product with a yield of 78.95%. The particle size of the rivaroxaban finished product was determined to be X 90 =5.60μm<15μm.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention provides a method for refining and crushing a rivaroxaban bulk drug, which comprises the following steps: adding a rivaroxaban crude product into an organic solvent, heating and completely dissolving, carrying out gradient cooling crystallization, filtering and drying to obtain rivaroxaban to be crushed, and crushing the rivaroxaban to be crushed through air flow to obtain a rivaroxaban finished product. In the refining process of the rivaroxaban crude product, gradient cooling crystallization is adopted during crystallization, solid particle suspension liquid with the particle size X90 being 200-300 microns can be obtained, solids in the solid particle suspension liquid are further filtered and separated out, and the obtained rivaroxaban with the particle size meeting X90lt is dried and smashed; and 15 [mu] m.

Description

technical field [0001] The invention relates to a method for refining and pulverizing rivaroxaban raw materials, belonging to the technical field of pharmaceutical preparation. Background technique [0002] Rivaroxaban is a highly selective factor Xa inhibitor, which can directly block the generation and burst of thrombin by specifically inhibiting factor Xa, thereby inhibiting the formation of thrombus. Its molecular formula is C19H 18 ClN 3 O 5 S, chemical name: 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxo oxazolidine-5-yl}-methyl)-2-thiophene-carboxamide, its structural formula is: [0003] [0004] Rivaroxaban is approved for the prevention of venous thrombosis (VTE) in adult patients undergoing hip or knee replacement surgery; and for the treatment of deep vein thrombosis (DVT) in adults, reducing DVT recurrence and pulmonary embolism (PE) after acute DVT )risks of. [0005] Rivaroxaban is practically insoluble in water and is a compound w...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D413/14
CPCC07D413/14
Inventor 黄乐群吴邵嘉汪静王磊郭露粉
Owner JIANGSU SINOBIOPHARMA